Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.36 |
| ▸ | HTR7 | P34969 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13367483 | 0.86 | SIGMAR1 (0.41) | SIGMAR1MAOAMAOBDHFRCYP2A6 | |
| SCHEMBL13367365 | 0.81 | MCL1 (0.41) | SIGMAR1DHFRKDM4EHTR1AHTR7 | |
| SCHEMBL13338595 | 0.81 | AKR1C3 (0.39) | SIGMAR1MAOAMAOBCYP2A6CYP1A2 | |
| SCHEMBL13367493 | 0.79 | CHRNA1 (0.40) | SIGMAR1MAOAMAOBCYP2A6CYP1A2 | |
| SCHEMBL27380432 | 0.78 | SLC6A9 (0.42) | SIGMAR1DHFRKDM4EALDH1A1CA12 | |
| SCHEMBL13367610 | 0.76 | SIGMAR1 (0.41) | SIGMAR1CYP1A2ALDH1A1HTR1AHTR7 | |
| SCHEMBL13367489 | 0.76 | SIGMAR1 (0.45) | SIGMAR1DHFRHTR1AHTR7 | |
| SCHEMBL5223360 | 0.76 | SIGMAR1 (0.50) | SIGMAR1CYP2A6CYP1A2KDM4EALDH1A1 | |
| SCHEMBL13367392 | 0.76 | CYP1A2 (0.44) | SIGMAR1DHFRCYP2A6CYP1A2KDM4E | |
| SCHEMBL12048739 | 0.76 | SIGMAR1 (0.50) | SIGMAR1DHFRCYP2A6CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | SIGMAR1 699/4885MAOA 1402/4885MAOB 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.